Skip to main content

Table 2 Share of positive recommendations and reimbursement decisions in analysed countries with respect to the type of approval

From: Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe

Country Approval type Recommendation Reimbursement Total
Positive Negative No recommendation Reimbursed Not reimbursed
Bulgaria Conditional approval 2 (22.22%) 0 (0%) 7 (77.78%) 2 (22.22%) 7 (77.78%) 9
  Exceptional circumstances 1 (50%) 0 (0%) 1 (50%) 1 (50%) 1 (50%) 2
  Unconditional 10 (40%) 0 (0%) 15 (60%) 10 (40%) 15 (60%) 25
  Total 13 (36.11%) 0 (0%) 23 (63.89%) 13 (36.11%) 23 (63.89%) 36
Croatia Conditional approval 1 (11.11%) 0 (0%) 8 (88.89%) 2 (22.22%) 7 (77.78%) 9
  Exceptional circumstances 0 (0%) 0 (0%) 2 (100%) 0 (0%) 2 (100%) 2
  Unconditional 9 (36%) 0 (0%) 16 (64%) 6 (24%) 19 (76%) 25
  Total 10 (27.78%) 0 (0%) 26 (72.22%) 8 (22.22%) 28 (77.78%) 36
Czechia Conditional approval 0 (0%) 0 (0%) 9 (100%) 0 (0%) 9 (100%) 9
  Exceptional circumstances 1 (50%) 0 (0%) 1 (50%) 0 (0%) 2 (100%) 2
  Unconditional 10 (40%) 0 (0%) 15 (60%) 10 (40%) 15 (60%) 25
  Total 11 (30.56%) 0 (0%) 25 (69.44%) 10 (27.78%) 26 (72.22%) 36
Estonia Conditional approval 2 (22.22%) 0 (0%) 7 (77.78%) 2 (22.22%) 7 (77.78%) 9
  Exceptional circumstances 0 (0%) 0 (0%) 2 (100%) 0 (0%) 2 (100%) 2
  Unconditional 11 (44%) 0 (0%) 14 (56%) 11 (44%) 14 (56%) 25
  Total 13 (36.11%) 0 (0%) 23 (63.89%) 13 (36.11%) 23 (63.89%) 36
Hungary Conditional approval 2 (22.22%) 1 (11.11%) 6 (66.67%) 2 (22.22%) 7 (77.78%) 9
  Exceptional circumstances 1 (50%) 0 (0%) 1 (50%) 1 (50%) 1 (50%) 2
  Unconditional 9 (36%) 4 (16%) 12 (48%) 9 (36%) 16 (64%) 25
  Total 12 (33.33%) 5 (13.89%) 19 (52.78%) 12 (33.33%) 24 (66.67%) 36
Latvia Conditional approval 1 (11.11%) 0 (0%) 8 (88.89%) 1 (11.11%) 8 (88.89%) 9
  Exceptional circumstances 0 (0%) 1 (50%) 1 (50%) 0 (0%) 2 (100%) 2
  Unconditional 3 (12%) 3 (12%) 19 (76%) 3 (12%) 22 (88%) 25
  Total 4 (11.11%) 4 (11.11%) 28 (77.78%) 4 (11.11%) 32 (88.89%) 36
Lithuania Conditional approval 0 (0%) 0 (0%) 9 (100%) 0 (0%) 9 (100%) 9
  Exceptional circumstances 0 (0%) 0 (0%) 2 (100%) 0 (0%) 2 (100%) 2
  Unconditional 10 (40%) 0 (0%) 15 (60%) 10 (40%) 15 (60%) 25
  Total 10 (27.78%) 0 (0%) 26 (72.22%) 10 (27.78%) 26 (72.22%) 36
Poland Conditional approval 2 (22.22%) 3 (33.33%) 4 (44.44%) 2 (22.22%) 7 (77.78%) 9
  Exceptional circumstances 1 (50%) 0 (0%) 1 (50%) 1 (50%) 1 (50%) 2
  Unconditional 8 (32%) 9 (36%) 8 (32%) 12 (48%) 13 (52%) 25
  Total 11 (30.56%) 12 (33.33%) 13 (36.11%) 15 (41.67%) 21 (58.33%) 36
Romania Conditional approval 1 (11.11%) 0 (0%) 8 (88.89%) 1 (11.11%) 8 (88.89%) 9
  Exceptional circumstances 1 (50%) 0 (0%) 1 (50%) 1 (50%) 1 (50%) 2
  Unconditional 6 (24%) 0 (0%) 19 (76%) 7 (28%) 18 (72%) 25
  Total 8 (22.22%) 0 (0%) 28 (77.78%) 9 (25%) 27 (75%) 36
Slovakia Conditional approval 0 (0%) 1 (11.11%) 8 (88.89%) 0 (0%) 9 (100%) 9
  Exceptional circumstances 0 (0%) 0 (0%) 2 (100%) 0 (0%) 2 (100%) 2
  Unconditional 10 (40%) 2 (8%) 13 (52%) 10 (40%) 15 (60%) 25
  Total 10 (27.78%) 3 (8.33%) 23 (63.89%) 10 (27.78%) 26 (72.22%) 36
  1. Unconditional means that neither conditional approval nor exceptional circumstances were granted